Interstate Commerce of Cannabis: The Impact and Aftermath of Siloed Markets

Nonhemp cannabis is legal for cultivation, manufacture, sale and use under the medical programs in 36 states, the District of Columbia and several U.S. territories. More than one-third of those jurisdictions also permit nonmedical or adult-use. Because nonhemp cannabis remains a Schedule I controlled substance under federal law, it cannot be sold, transported or shipped across state lines, creating a patchwork of intrastate cannabis economies. In this webinar, panelists will discuss a range of topics related to the interstate commerce ban, including licensee residency requirements adopted in many states (and associated litigation); the Dormant Commerce Clause; economic, social equity and environmental implications of closed markets; and the possibility of interstate compacts as a stopgap pending federal legalization. Speakers will also address the ban’s impact on medical patients and how pending legislation and post-legalization regulatory schemes may impact licensed operators and other industry participants.

Moderator:

Phillip Neiman, Esq., FCIArb | JAMS

Speakers:

Jennifer Cabrera, Esq. | Vicente Sederberg LLP